Business Context and Reporting Period
This Form 8-K Current Report, dated May 21, 2026, details a material definitive agreement entered into by Hims & Hers Health, Inc. (the "Company"). The filing reports the issuance of convertible senior notes and the execution of related capped call transactions to manage potential equity dilution.
Key Financial Metrics and Transaction Details
- Debt Issuance: The Company issued $402.5 million aggregate principal amount of 0.00% Convertible Senior Notes due 2032.
- Offering Structure: The issuance consisted of an initial $350.0 million offering plus a full exercise of a $52.5 million option by initial purchasers.
- Interest Rate: The Notes bear 0.00% interest and do not accrete principal.
- Maturity Date: June 1, 2032.
- Conversion Terms:
- Initial conversion rate: 33.8590 shares per $1,000 principal amount.
- Initial conversion price: Approximately $29.53 per share.
- Settlement: Cash, shares, or a combination at the Company's election.
- Capped Call Transactions:
- Cost: Approximately $36.7 million.
- Cap Price: Approximately $50.15 per share (125.0% premium over the May 18, 2026 closing price).
- Purpose: To offset potential dilution and cash payments upon conversion.
- Maximum Dilution: Up to 18,057,397 shares of Class A common stock may be issued upon conversion.
Material Changes Versus Prior Period
This filing represents a discrete capital market event rather than a periodic financial performance report. Consequently, there are no comparative revenue, profit, or cash flow metrics provided in this document. The primary material change is the addition of $402.5 million in senior unsecured debt obligations and the associated contingent equity liability.
Guidance, Outlook, and Risks
- Redemption Rights: The Company may redeem the Notes on or after June 6, 2029, subject to liquidity conditions and if the stock price exceeds 130% of the conversion price for a specified period.
- Fundamental Change Repurchase: Upon certain corporate events (e.g., business combinations, delisting), noteholders may require the Company to repurchase the Notes at par plus accrued interest.
- Events of Default: Includes payment defaults, failure to convert, bankruptcy, and defaults on other indebtedness exceeding $30 million.
- Subordination: The Notes are senior unsecured obligations but are structurally subordinated to subsidiary liabilities and effectively subordinated to secured indebtedness.
- Management Commentary: The filing does not contain forward-looking guidance on revenue or earnings, focusing strictly on the terms of the debt instrument.
Investor Verification Checklist
- Verify the impact of the $36.7 million cost of the capped call transactions on the Company's immediate cash position and balance sheet.
- Confirm the conversion price of $29.53 relative to the current trading price of HIMS stock to assess immediate dilution risk.
- Review the liquidity conditions required for the Company to redeem the Notes after 2029.
- Assess the Company's ability to service the debt given the 0.00% coupon structure, noting that cash outflows will primarily occur upon conversion or maturity.
- Examine the Indenture (Exhibit 4.1) for specific covenants regarding asset sales, mergers, and additional indebtedness.